Medical News

RSS

Global Summit on Nurse Faculty Migration to identify solutions for shortage of nurse faculty

The global nursing shortage is due in part to a lack of faculty in nursing schools and to a phenomenon known as nurse migration, where nurses leave their country of origin to work elsewhere. In response, the International Council of Nurses and the Honor Society of Nursing, Sigma Theta Tau International, supported by The Elsevier Foundation, will conduct the Global Summit on Nurse Faculty Migration-a meeting of nurse experts who will examine the problem, and identify realistic and measurable solutions.

7 Apr 2010

Therapeutic swing for autism-spectrum disorder sheds metallic particles directly into eyes of children

The presence of metallic foreign bodies in the eye is an uncommon injury in children, so much so that two children with autism presenting with this injury led to detective work by two physicians that found the common cause.

7 Apr 2010

Officials of Kylin Therapeutics receive an issued patent from USPTO

Officials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office.

7 Apr 2010

Researchers commence Phase 2 research study to test CERE-110 for AD

Researchers at Banner Sun Health Research Institute are about to start the first Phase 2 research study to test a gene transfer agent for Alzheimer's disease. AD is a degenerative and ultimately fatal disorder affecting as many as five million Americans and that number is expected to soar to more than 11 million by 2040.

7 Apr 2010

Study provides benchmark data to evaluate quality of management of sickle cell disease

The largest study to date of the use of acute care medical services by people with sickle cell disease found four of every 10 had to return to the hospital within 30 days of a previous hospitalization or go to the emergency department for treatment of pain, according to a new study funded in part by HHS' Agency for Healthcare Research and Quality.

7 Apr 2010

Measure of blood flow in lungs could help identify smokers at risk of emphysema

Using CT scans to measure blood flow in the lungs of people who smoke may offer a way to identify which smokers are most at risk of emphysema before the disease damages and eventually destroys areas of the lungs, according to a University of Iowa study.

7 Apr 2010

NNIT selects Verizon Business to manage global communications infrastructure for Novo Nordisk

NNIT, a leading Danish IT consultancy, has chosen Verizon Business to deploy and manage a global communications infrastructure for Novo Nordisk, the global health care company. A fully managed Verizon Private IP solution will provide secure, scalable and flexible connectivity for 75 of Novo Nordisk's locations around the world, helping the company to streamline its global operations, while also realizing cost and management efficiencies.

7 Apr 2010

Tigermed Consulting signs alliance agreement with ICON

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries and Tigermed Consulting, a leader in the provision of clinical drug development services in China, today announced that they have signed an alliance agreement.

7 Apr 2010

Research highlights first steps in the formation of Lewy bodies, the hallmark of Parkinson's brain

Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.

7 Apr 2010

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

The Muscular Dystrophy Association (MDA), headquartered in Tucson, Ariz., and Friends of FSH Research (FFSHR), based in Kirkland, Wash., has jointly awarded a two-year, $200,000 grant to Dr. Joel Chamberlain, a research assistant professor of medical genetics at the University of Washington. The grant, equally funded by the two organizations, will enable the laboratory led by Dr. Chamberlain to study RNA interference as an investigative and therapeutic tool for facioscapulohumeral muscular dystrophy.

7 Apr 2010

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

The Semel Institute for Neuroscience and Human Behavior at UCLA has been awarded $14.9 million in American Recovery and Reinvestment Act funds to establish a center dedicated to interdisciplinary research on the role of genetic and environmental factors in neuropsychiatric and behavioral disorders.

7 Apr 2010

Nile Therapeutics to fund ongoing Phase II clinical trial of CD-NP with proposed public offering

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced today that it intends to offer units consisting of shares of its common stock and warrants to purchase shares of its common stock in a public offering. Maxim Group LLC is acting as the sole book-running manager for this offering, with Ladenburg Thalmann & Co. Ltd. as co-manager.

7 Apr 2010

Stimulant medication normalizes brain function in children with ADHD: Study

Attention-deficit/hyperactivity disorder is one of the most common mental health disorders affecting children and adolescents. Children with ADHD are excessively restless, impulsive, and distractible and experience difficulties at home and in school. Problems inhibiting behavior are a common theme for ADHD symptoms.

7 Apr 2010

Promising treatment for children with high-functioning autism spectrum disorders

A unique treatment program at Canisius College offers hope to children with high-functioning autism spectrum disorders (Asperger's, high-functioning autism, and PDDNOS), which are characterized by lifelong impairments in social-communicative functioning and narrow and repetitive behaviors and interests.

7 Apr 2010

TD2 to join GPEC at BayBio2010 to spur Arizona's bioscience industry

Scottsdale-based TGen Drug Development will join the Greater Phoenix Economic Council this week at BayBio2010 in an effort to spur Arizona's bioscience industry.

7 Apr 2010

UHC awards dual 3-year agreements to UHS, Crothall Services Group

University HealthSystem Consortium today announced that after a competitive bid process, it has awarded dual 3-year agreements for clinical/diagnostic equipment maintenance services to Universal Hospital Services, Inc. and Crothall Services Group. Contracts were effective January 1, 2010 and February 1, 2010 respectively.

7 Apr 2010

Senator Grassley issues warning about 'phanton pharmacies' while Tampa officials arrest pharmacists on fraud charges

Senator Charles Grassley, R-Iowa, wrote a letter to Department of Health and Human Services Secretary Kathleen Sebelius this week saying federal officials have failed to stop the growing trend of "phantom pharmacies" that bill millions to Medicare in prescription drug costs then disappear, ABC News reports.

7 Apr 2010

Medical News

Global Summit on Nurse Faculty Migration to identify solutions for shortage of nurse faculty

Therapeutic swing for autism-spectrum disorder sheds metallic particles directly into eyes of children

Officials of Kylin Therapeutics receive an issued patent from USPTO

Researchers commence Phase 2 research study to test CERE-110 for AD

Study provides benchmark data to evaluate quality of management of sickle cell disease

Measure of blood flow in lungs could help identify smokers at risk of emphysema

NNIT selects Verizon Business to manage global communications infrastructure for Novo Nordisk

Tigermed Consulting signs alliance agreement with ICON

Research highlights first steps in the formation of Lewy bodies, the hallmark of Parkinson's brain

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

Nile Therapeutics to fund ongoing Phase II clinical trial of CD-NP with proposed public offering

Stimulant medication normalizes brain function in children with ADHD: Study

Promising treatment for children with high-functioning autism spectrum disorders

TD2 to join GPEC at BayBio2010 to spur Arizona's bioscience industry

UHC awards dual 3-year agreements to UHS, Crothall Services Group

Senator Grassley issues warning about 'phanton pharmacies' while Tampa officials arrest pharmacists on fraud charges

Sickle cell disease: Rehospitalization rates high

AHRQ: Women accounted for nearly 60% of 39.4M admissions to U.S. hospitals in 2007

Liver transplant loan repayment expected says WA Premier

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News